newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Reports First Quarter 2025 Financial Results

--Preparing for Potential Launch of ORLYNVAHTM by Q4 2025-- --Extended Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) --